Development of Chinese medicine research in Hong Kong, China in last decade

Ai-ping Lu; Shi-ping Cheng; Biao Liu

doi:10.1007/s11655-017-2816-y

Your Location：

Home >

Browse articles >

Development of Chinese medicine research in Hong Kong, China in last decade

Updated：2021-08-27

- Development of Chinese medicine research in Hong Kong, China in last decade
- Chinese Journal of Integrative Medicine Vol. 23, Issue 7, Pages: 483-485(2017)
- Affiliations：
  
  1. School of Chinese Medicine, Hong Kong Baptist University,Hong Kong SAR,China
  2. School of Nursing, Jiangxi University of Traditional Chinese Medicine,Nanchang,China
- Author bio：
- Funds：
- DOI：10.1007/s11655-017-2816-y
  CLC：
- Published：2017，
  
  Published Online：17 June 2017，
Scan for full text
Lu, Ap., Cheng, Sp. & Liu, B. Development of Chinese medicine research in Hong Kong, China in last decade., Chin. J. Integr. Med. 23, 483–485 (2017). https://doi.org/10.1007/s11655-017-2816-y

Ai-ping Lu, Shi-ping Cheng, Biao Liu. Development of Chinese medicine research in Hong Kong, China in last decade. [J]. Chinese Journal of Integrative Medicine 23(7):483-485(2017)
Lu, Ap., Cheng, Sp. & Liu, B. Development of Chinese medicine research in Hong Kong, China in last decade., Chin. J. Integr. Med. 23, 483–485 (2017). https://doi.org/10.1007/s11655-017-2816-y DOI：

Ai-ping Lu, Shi-ping Cheng, Biao Liu. Development of Chinese medicine research in Hong Kong, China in last decade. [J]. Chinese Journal of Integrative Medicine 23(7):483-485(2017) DOI： 10.1007/s11655-017-2816-y.

摘要

Abstract

关键词

Keywords

references

Available at http://www.ugc.edu.hk/chs/rgc/index.html

Available at http://www.itc.gov.hk/ch/about/index.htm

Available at http://rfs2.fhb.gov.hk/chs/funds/funds_hmrf/funds_ hmrf_abt/funds_hmrf_abt.html

Available at http://www.ugc.edu.hk/eng/ugc/activity/research/rae. html

Wang C, Liu B, Xu X, Zhuang B, Li H, Yin J, et al. Toward targeted therapy in chemotherapy-resistant pancreatic cancer with a smart triptolide nanomedicine. Oncotarget 2016;7:8360–8372.

Chu ES, Sze SC, Cheung HP, Wong KL, Liu Q, Ng TB, et al. Differential effects of anti-metastatic mechanism of Tian-Xian Liquid (TXL) and its bioactive fractions on human colorectal cancer models. J Ethnopharmacol 2011;137:403–413.

Zhong LL, Cheng CW, Chan Y, Chan KH, Lam TW, Chen XR, et al. Chinese herbal medicine (Ma Zi Ren Wan) for functional constipation: study protocol for a prospective, double-blinded, double-dummy, randomized controlled trial. Trials 2013;14:366.

China Academy of Chinese Medical Sciences. Evidence-based guideline of clinical practice in Chinese medicine. Beijing: China Traditional Medicine Press; 2011.

Yuwen Y, Shi NN, Han XJ, Gao Y, Xu JL, Liu DS, et al. Appraisal of clinical practice guidelines for ischemic stroke management in Chinese medicine with appraisal of guidelines for research and evaluation instrument: a systematic review. Chin J Integr Med 2015;21:707–715.

Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, et al. AGREE II: advancing guideline development, reporting, and evaluation in health care. Prev Med 2010;51:421–424.

FULL TEXT LINK

More>

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

No data

Related Author

No data

Related Institution

No data

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰